Skip to content

Clinical trials

Active, not recruiting Lung Diseases, Interstitial trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Active, not recruiting Country / region: United Kingdom Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20181
20221
20233
20243
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Andreas Guenther1
AstraZeneca1
Avalyn Pharma Inc.1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Imperial College Healthcare NHS Trust1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Novartis Pharmaceuticals1
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Pulmovant, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial13
Scleroderma, Diffuse4
Pulmonary Fibrosis3
Autoimmune Diseases2
Carcinoma, Non-Small-Cell Lung2
Fibrosis2
Immune System Diseases2
Scleroderma, Systemic2
Alveolitis, Extrinsic Allergic1
Arthritis, Rheumatoid1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.